306-O12B

• CAT Number: I041108
• CAS Number: 2566523-06-4
• Molecular Formula: C59H115N3O8S8
• Molecular Weight: 1251.08
• Purity: ≥95%
• Synonyms: 2-(octyldisulfanyl)ethyl 3-[3-[3-[bis[3-[2-(octyldisulfanyl)ethoxy]-3-oxopropyl]amino]propyl-methylamino]propyl-[3-[2-(octyldisulfanyl)ethoxy]-3-oxopropyl]amino]propanoate
• InChI: InChI=1S/C59H115N3O8S8/c1-6-10-14-18-22-26-48-71-75-52-44-67-56(63)32-40-61(41-33-57(64)68-45-53-76-72-49-27-23-19-15-11-7-2)38-30-36-60(5)37-31-39-62(42-34-58(65)69-46-54-77-73-50-28-24-20-16-12-8-3)43-35-59(66)70-47-55-78-74-51-29-25-21-17-13-9-4/h6-55H2,1-5H3
• InChIKey: FTXIINBPTFOCHN-UHFFFAOYSA-N
• SMILES: CCCCCCCCSSCCOC(=O)CCN(CCCN(C)CCCN(CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC)CCC(=O)OCCSSCCCCCCCC

306-O12B（Cat No.:I041108）is a novel small molecule compound under investigation for its potential therapeutic applications, particularly in oncology. It is designed to target specific signaling pathways involved in tumor growth, progression, and metastasis. Preclinical studies suggest that 306-O12B may inhibit the proliferation of cancer cells by modulating key proteins and enzymes involved in cell cycle regulation. Ongoing research aims to assess its effectiveness and safety in treating various types of cancers, including solid tumors and hematological malignancies. If successful, 306-O12B could offer a new treatment option for patients with resistant or advanced cancers.